Guidelines recommend keeping family close during ICU admission

The Society of Critical Care Medicine (SCCM) has developed a set of guidelines for promoting family-centered care in intensive care units to lessen the effects of post-intensive care syndrome, a set of health disorders common in those who survive critical illness and intensive care.

Admission into the ICU can be a traumatic experience for patients and families, often leaving both with lingering physical and mental strain. In response, a multidisciplinary international expert panel has developed guidelines to assist in the implementation of family-centered care within the ICU. These guidelines and supporting tools, which have already been endorsed by nine international critical care and family-centered care specialty organizations, focus on incorporating families in the care and recovery of the patient.

"These guidelines identify the evidence base for best practices for family-centered care in the ICU," said lead author Judy E. Davidson, DNP, RN, of the University of California San Diego Health.

Analyzing data from more than 450 qualitative and quantitative studies, experts created 23 recommendations grouped into five areas. These recommendations include family presence within the ICU, supporting and improve family knowledge, and specific consultations with family members. Each recommendation is paired with evidence supporting the importance of family-centered care.  

“One of the key findings from these guidelines is that there are many important areas of family-centered care where the evidence-base is inadequate. The guidelines highlight key areas for future research," comments senior author J. Randall Curtis, MD, MPH, of the University of Washington, Seattle.

"Family presence, improved communication and family engagement in care may reduce post-intensive care syndrome for both patients and their family members, ultimately improving the health of our community," said Davidson. "Families in the ICU aren't visitors—they should be an integral part of the care and the care team."

 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.